Funding profile · Digital health, patient engagement

Framewise Health

A two month old Y Combinator company with one funding event on the record: a $500,000 accelerator investment reported by PitchBook. No SEC Form D has been filed under the company’s name.

$500KY Combinator accelerator investment, PitchBook, dated May 1, 2026
$0Amount reported in SEC Form D filings under the company’s name
1Investor named on the record: Y Combinator
2Employees reported by PitchBook and Y Combinator

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
May 1, 2026 Accelerator/Incubator $500,000 Y Combinator PitchBook
Through Sep 2026 SEC Form D None found n/a Not found

What the filings show

No Form D notice has been filed under Framewise Health, Inc. or a similar entity name as of September 25, 2026, in the records compiled for this profile. The single financing event on record comes from PitchBook, a third party data vendor, not from an SEC filing. PitchBook classifies the deal as an Accelerator/Incubator investment of $500,000 dated May 1, 2026, with Y Combinator listed as the sole investor and no post money valuation disclosed. PitchBook also marks the company’s deal status as Completed and its stage as Generating Revenue, both PitchBook designations rather than company-published figures.

Reading the filings

  1. The only funding event on record is the accelerator check.PitchBook lists a single deal, an Accelerator/Incubator investment of $500,000 on May 1, 2026, with Y Combinator as the only investor named. That figure is consistent with the size of a typical Y Combinator batch investment, though the company has not published its own terms.
  2. No Form D has been filed under the company’s name.A search of SEC records for Framewise Health, Inc. and related entity names turned up no Form D notice as of September 25, 2026. A company can raise money without filing Form D if it relies on an exemption other than Regulation D, or if it simply has not yet filed one for a small early round, so the absence does not rule out other money having moved.
  3. PitchBook’s revenue stage claim has no public backing.PitchBook lists the company’s stage as Generating Revenue, but no revenue figure, named customer or press report confirms paying customers exist.
  4. Team size matches the founder count.Both Y Combinator’s company page and PitchBook list two employees, matching the two co-founders, Tane Kim and David Cui, named in the company’s own launch post. No additional hires appear on either record.

Commercial signals

Signal Detail Source type
Accelerator Y Combinator, Spring 2026 batch, status active, primary partner Aaron Epstein. Public record
Regulatory No FDA 510(k) or PMA record found for the company. Not found
Clinical evidence No registered clinical trial, NIH award or PubMed record matched to the company. Not found
Customers Site offers a demo request. No hospital, pharma company or clinic is named as a paying customer. Not found
Integrations claimed Site states it works with Epic, Oracle Health (Cerner), Athenahealth, ModMed, eClinicalWorks, NextGen and any FHIR R4 endpoint. Company-stated

What to watch

  • A Form D, if the company raises capital outside the Y Combinator check.
  • Named hospital, pharma or clinic customers.
  • Whether PitchBook’s Generating Revenue label is followed by a disclosed revenue figure.
  • Any independent press coverage once the company has a track record to report on.

The Framewise Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • CareMessage: Similar focus. A 501(c)(3) nonprofit that sends text messages on behalf of the clinics serving America’s poorest patients
  • Pharos: Similar focus. An AI system that reads hospital charts and produces the quality measures nurses now extract by hand
  • Adentris: Similar focus. An AI compliance copilot that reads hospital and clinic EHRs the way a trained reviewer would, looking for documentation gaps before they turn into denied claims
  • Juno: Similar focus. A chat and voice app that asks people with chronic illness how they feel, logs the answer, and turns weeks of messy symptom notes into a summary for the next doctor's

Sources

  1. IndependentFramewise Health company profilePitchBook · accessed Jul 31, 2026
  2. Public recordFramewise Health company page, Y Combinator directoryY Combinator · accessed Sep 25, 2026
  3. CompanyFramewise Health homepageframewisehealth.com · accessed Sep 25, 2026
  4. Public recordCompiled SEC Form D, FDA, FDA PMA, ClinicalTrials.gov, NIH, NSF and PubMed record search for Framewise HealthCompany profile records file · Sep 25, 2026
  5. IndependentFramewise Health entry, Spring 2026 batchThe YC Tier List · accessed Sep 25, 2026

Compiled from SEC, FDA, NIH, NSF and PitchBook records and published pages as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and no such filing was found for this company. Healthcare Venture Capital Fund holds no position in Framewise Health. This page is not an offer to sell or a recommendation to buy any security.